Dihydrouracil Dehydrogenase (NADP) [dihydrouracildehydrogenasa (NADP)]
topical
10
- Terms
-
dehydrogenasa dihydrouracilu
dihydropyrimidindehydrogenasa
dihydropyrimidindehydrogenáza
dihydrouracildehydrogenáza (NADP)
-
Dihydropyrimidine Dehydrogenase
Dihydrothymine Dehydrogenase (NADP)
Persistent link
https://www.medvik.cz/link/D042943
Definition
An oxidoreductase involved in pyrimidine base degradation. It catalyzes the catabolism of THYMINE; URACIL and the chemotherapeutic drug, 5-FLUOROURACIL.
- DUI
- D042943 MeSH Browser
- CUI
- M0073263
- Previous indexing
- Oxidoreductases (1980-2003); Uracil (1979)
- History note
- 2004; use DIHYDROURACIL DEHYDROGENASE (NADP) (NM) 1980-2003
- Public note
- 2004; DIHYDROURACIL DEHYDROGENASE (NADP) was indexed under OXIDOREDUCTASES 1983-2003; & under URACIL 1979
Combination
- deficiency
- Dihydropyrimidine Dehydrogenase Deficiency
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AN
- analysis
- AI
- antagonists & inhibitors 1
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics 6
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 4
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PH
- physiology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D08.811.682.660.275
Dihydrodipicolinate Reductase
D08.811.682.660.300
Dihydroorotate Oxidase
D08.811.682.660.390
Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific)
D08.811.682.660.490
15-Oxoprostaglandin 13-Reductase
D08.811.682.660.495
Lamin B Receptor
D08.811.682.660.500
Prephenate Dehydrogenase